Magnera (MAGN) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Aug, 2026Executive summary
Achieved record third quarter with net sales of $857 million and adjusted EBITDA of $99 million, up 9% year-over-year, driven by organic volume growth, synergy initiatives, and strong performance in wipes and infrastructure segments.
Transformation initiatives, including Project CORE and merger synergies, delivered significant savings and operational improvements.
Maintained resilience through a balanced portfolio of essential consumer and personal care products, with operations organized into Americas and Rest of World segments.
Twelve-month adjusted free cash flow yield exceeded 25% at quarter-end.
The company continues to pursue acquisitions to enhance market position and product lines.
Financial highlights
Net sales reached $857 million, up 2% year-over-year from $839 million, with operating income rising to $22 million from $13 million.
Adjusted EBITDA for the quarter was $99 million, a 9% increase from $91 million year-over-year.
Americas segment adjusted EBITDA rose 16% to $71 million, while Rest of World adjusted EBITDA declined 7% to $28 million.
Net loss for the quarter was $20 million, or $(0.56) per share, compared to a net loss of $18 million, or $(0.51) per share, in the prior year.
Free cash flow for the quarter was $32 million, with year-to-date free cash flow at $32 million.
Outlook and guidance
Full-year free cash flow guidance reaffirmed at $90–$110 million, with adjusted EBITDA expected at the lower end of the previous range due to inflation and macro uncertainty.
Fiscal 2026 cash from operations projected between $150–$170 million, assuming $60 million in capital spending.
CapEx expected to be around $60 million for the year, with flexibility for future growth investments.
Management expects long-term demand fundamentals to remain strong despite macroeconomic challenges.
Latest events from Magnera
- Integration and innovation drive growth, with major synergies expected by 2027.MAGN
Wells Fargo Industrials & Materials Conference 2025 - Adjusted EBITDA was $90M, free cash flow $73M, net sales down 3%, guidance reaffirmed.MAGN
Q2 2026 - 2026 guidance targets EBITDA growth, debt reduction, and expansion in key nonwoven markets.MAGN
Sidoti March Small-Cap Virtual Conference - All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 2026 - Net sales up 13% to $792M, adjusted EBITDA up 11%, and 2026 guidance reaffirmed.MAGN
Q1 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong ESG focus.MAGN
Proxy filing - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing - 2026 EBITDA expected to grow 9% as synergy realization and innovation drive margin expansion.MAGN
Q4 2025 - Q1 sales surged 35% to $702M post-merger, with EBITDA up 8% and strong synergy execution.MAGN
Q1 2025